Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis

Arthritis and Rheumatology

Volumn 66, Issue 4, 2014, Pages 863-873

  Lee, Hwa Suk ^a   Woo, Seong Ji ^a   Koh, Hyoung Won ^a   Ka, Sun O ^a   Zhou, Lu ^a   Jang, Kyu Yun ^a   Lim, Hye Song ^b   Kim, Hyun Ok ^b   Lee, Sang Il ^b   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLLAGEN; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MATRIX METALLOPROTEINASE; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME RELEASE; EVALUATION STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; FIBROBLASTS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MATRIX METALLOPROTEINASES; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898623367     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38303     Document Type: Article

References (33)

1. Firestein GS,. Evolving concents of rheumatoid arthritis. Nature 2003; 423: 356-61.
2. Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S,. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005; 1: 102-10.
3. Bartok B, Firestein GS,. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233-55.
4. Noss EH, Brenner MB,. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008; 223: 252-70.
5. Baier A, Meineckel I, Gay S, Pap T,. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 274-9.
6. Hah YS, Lee YR, Jun JS, Lim HS, Kim HO, Jeong YG, et al. A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. Arthritis Rheum 2010; 62: 2313-21.
7. Tak PP, Firestein GS,. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11.
8. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P,. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-74.
9. Yakar S, Wu Y, Setser J, Rosen CJ,. The role of circulating IGF-I: lessons from human and animal models. Endocrine 2002; 19: 239-48.
10. Jogie-Brahim S, Feldman D, Oh Y,. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev 2009; 30: 417-37.
11. Han J, Jogie-Brahim S, Harada A, Oh Y,. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling. Cancer Lett 2011; 307: 200-10.
12. Zhong Y, Lu L, Zhou J, Li Y, Liu Y, Clemmons DR, et al. IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos. J Cell Sci 2011; 124: 1925-35.
13. H-Zadeh AM, Collard TJ, Malik K, Hicks DJ, Paraskeva C, Williams AC,. Induction of apoptosis by the 16-kDa amino-terminal fragment of the insulin-like growth factor binding protein 3 in human colonic carcinoma cells. Int J Oncol 2006; 29: 1279-86.
14. Williams AC, Smartt H, H-Zadeh AM, MacFarlane M, Paraskeva C, Collard TJ,. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-κB. Cell Death Differ 2007; 14: 137-45.
15. Lee YC, Jogie-Brahim S, Lee DY, Han J, Harada A, Murphy LJ, et al. Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem 2011; 286: 17898-909.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Lee YR, Hwang JK, Lee HS, Cheon YJ, Ryu JH, Lee SI, et al. SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis. Br J Pharmacol 2011; 164: 794-806.
18. Lee HS, Ka SO, Lee SM, Lee SI, Park JW, Park BH,. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. Arthritis Rheum 2013; 65: 1776-85.
19. Brand DD, Latham KA, Rosloniec EF,. Collagen-induced arthritis. Nat Protoc 2007; 2: 1269-75.
20. Bostrom EA, Svensson M, Andersson S, Jonsson IM, Ekwall AK, Eisler T, et al. Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis. Arthritis Rheum 2011; 63: 2894-904.
21. Neidel J,. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis. Clin Exp Rheumatol 2001; 19: 81-4.
22. Yoo SA, You S, Yoon HJ, Kim DH, Kim HS, Lee K, et al. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J Exp Med 2012; 209: 871-86.
23. Fernihough JK, Billingham ME, Cwyfan-Hughes S, Holly JM,. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum 1996; 39: 1556-65.
24. Matsumoto T, Tsurumoto T,. Inappropriate serum levels of IGF-I and IGFBP-3 in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 352-3.
25. Price WA, Moats-Staats BM, Stiles AD,. Pro- and anti-inflammatory cytokines regulate insulin-like growth factor binding protein production by fetal rat lung fibroblasts. Am J Respir Cell Mol Biol 2002; 26: 283-9.
26. Oh Y, Muller HL, Lamson G, Rosenfeld RG,. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells: cell surface binding and growth inhibition. J Biol Chem 1993; 268: 14964-71.
27. Oh Y, Muller HL, Pham H, Rosenfeld RG,. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993; 268: 26045-8.
28. Schedlich LJ, Young TF, Firth SM, Baxter RC,. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998; 273: 18347-52.
29. Haupl T, Yahyawi M, Lubke C, Ringe J, Rohrlach T, Burmester GR, et al. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen 2007; 12: 328-40.
30. Butt AJ, Firth SM, King MA, Baxter RC,. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 2000; 275: 39174-81.
31. Silha JV, Mishra S, Rosen CJ, Beamer WG, Turner RT, Powell DR, et al. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Min Res 2003; 18: 1834-41.
32. Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A,. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. Bone 1995; 16: 263S-9S.
33. Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, et al. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 2002; 87: 1593-9.